Skip to main content

ORIGINAL RESEARCH article

Front. Oncol., 24 February 2022
Sec. Neuro-Oncology and Neurosurgical Oncology
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.770013
This article is part of the Research Topic The Advances in Proteomics and Targeted Therapy of Malignant Brain Tumours View all 8 articles

RETRACTED: ZNF655 Promotes the Progression of Glioma Through Transcriptional Regulation of AURKA

Retracted

A retraction of this article was approved in:

  1. Retraction: ZNF655 promotes the progression of glioma through transcriptional regulation of AURKA

    1. Read retraction
Xu Chen&#x;Xu Chen1†Chao Liu&#x;Chao Liu2†Zhenyu ZhangZhenyu Zhang2Meng WangMeng Wang2Shewei GuoShewei Guo2Tianhao LiTianhao Li2Hongwei SunHongwei Sun2Peng Zhang*Peng Zhang2*
  • 1Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, China
  • 2Department of Neurosurgery of the First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Chen X, Liu C, Zhang Z, Wang M, Guo S, Li T, Sun H and Zhang P (2022) ZNF655 Promotes the Progression of Glioma Through Transcriptional Regulation of AURKA. Front. Oncol. 12:770013. doi: 10.3389/fonc.2022.770013

Received: 03 September 2021; Accepted: 10 January 2022;
Published: 24 February 2022; Retracted: 19 October 2023.

Edited by:

Jose R. Pineda, University of the Basque Country, Spain

Reviewed by:

Ann-Christin Hau, Laboratoire National de Santé (LNS), Luxembourg
Sonikpreet Aulakh, West Virginia University, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.